Microneedling vs Dermabrasion for Early Facial Scar Resurfacing
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Dec 5, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two treatments, microneedling and dermabrasion, to see which one works better for improving the appearance of facial scars after surgery. The goal is to find out which method helps make surgical scars on the face look better in the early stages of healing.
To participate in the study, you need to be an adult who is 18 years or older and have a specific type of vertical scar on the upper part of your face. You can learn more and express your interest by visiting the Facial Plastics and Reconstructive Surgery Clinic at Atrium Health Wake Forest Baptist. If you are eligible and choose to participate, you will receive one of the two treatments and help researchers understand which method is more effective for scar improvement. It's important to know that certain skin types will not be included in the study to ensure safety and better outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Volunteer adult patients will be identified by visiting the Facial Plastics and Reconstructive Surgery Clinic at Atrium Health Wake Forest Baptist.
- • Patients will be 18 years old+ and have a vertical surgical scar in the superior 1/3 of the face (trichion to glabella).
- • Patients will enroll in the clinic research registry and indicate an interest in being involved in the study.
- Exclusion Criteria:
- • Patients who rate Types 4-6 on the Fitzpatrick scale will be excluded due to risk of poor outcome from dermabrasion.
- • There are no other planned exclusion criteria. Patients will not be excluded on the basis of gender, race/ethnicity, or age, provided that they meet the described inclusion criteria.
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winston Salem, North Carolina, United States
Patients applied
Trial Officials
Candace M Water, MD
Principal Investigator
Wake Forest University Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported